Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director departure
Inv. presentation
Quarterly results

Sonnet BioTherapeutics Holdings, Inc. (BURG) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
09/28/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
08/22/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
08/22/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/21/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update"
08/10/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/09/2023 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
08/07/2023 ARS Form ARS - Annual Report to Security Holders:
08/07/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/07/2023 SC 13G/A Markey John reports a 10.7% stake in Sonnet BioTherapeutics Holdings, Inc.
07/28/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
07/28/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
07/17/2023 D Form D - Notice of Exempt Offering of Securities:
07/17/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/07/2023 SC 13G/A Markey John reports a 9.9% stake in Sonnet BioTherapeutics Holdings, Inc.
06/30/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "PRE-FUNDED COMMON STOCK PURCHASE WARRANT SONNET BIOTHERAPEUTICS HOLDINGS, INC. Warrant Shares: [______] Issue Date: [______], 2023 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT certifies that, for value received, [______] or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and until this Warrant is exercised in full but not thereafter, to subscribe for and purchase from Sonnet BioTherapeutics Holdings, Inc., a Delaware corporation , up to [______] shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and not otherwise defined her...",
"COMMON STOCK PURCHASE WARRANT SONNET BIOTHERAPEUTICS HOLDINGS, INC. Warrant Shares: [______] Issue Date: [______], 2023 Initial Exercise Date: [_______] 1 , 2023 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, [______] or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on [______], 20[__] 2 but not thereafter, to subscribe for and purchase from Sonnet BioTherapeutics Holdings, Inc., a Delaware corporation , up to [______] shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized term...",
"PLACEMENT AGENT WARRANT SONNET BIOTHERAPEUTICS HOLDINGS, INC. Warrant Shares: [______] Issue Date: [______], 2023 Initial Exercise Date: [______] 1 , 2023 THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT certifies that, for value received, [______] or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above and on or prior to 5:00 p.m. on [______], 20[__] 2 but not thereafter, to subscribe for and purchase from Sonnet BioTherapeutics Holdings, Inc., a Delaware corporation , up to [______] shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. This Warrant is being issued purs...",
"Sonnet BioTherapeutics Holdings, Inc. 100 Overlook Center, Suite 102 Princeton, New Jersey 08540",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of June 28, 2023, between Sonnet BioTherapeutics Holdings, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , as to the Shares, the Prefunded Warrants and Prefunded Warrant Shares and an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4 thereof and/or Regulation D promulgated thereunder as to the Common Warrants , the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the ...",
"Sonnet BioTherapeutics Announces $2.25 Million Registered Direct Offering and Concurrent Private Placement"
06/30/2023 SC 13G Markey John reports a 8.5% stake in Sonnet BioTherapeutics Holdings, Inc.
06/29/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/12/2023 SC 13G Markey John reports a 9.9% stake in Sonnet BioTherapeutics Holdings, Inc.
06/09/2023 SC 13G Ruck Matthew J reports a 5.6% stake in Sonnet BioTherapeutics Holdings, Inc.
05/31/2023 4 Dyrness Albert D. (Director) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.
Txns: Bought 23,255 shares @ $0.468, valued at $10.9k
05/26/2023 SC 13G/A Markey John reports a 8.4% stake in Sonnet BioTherapeutics Holdings, Inc.
05/18/2023 4 Bhatt Nailesh (Director) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.
Txns: Bought 25,000 shares @ $0.232, valued at $5.8k
05/15/2023 4 Mohan Pankaj (Chairman, President and CEO) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.
Txns: Bought 371,600 shares @ $0.223, valued at $82.9k
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Quarterly results
05/01/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/18/2023 8-K Quarterly results
03/24/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
03/16/2023 4 Mohan Pankaj (Chairman, President and CEO) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.
Txns: Bought 60,000 shares @ $0.585, valued at $35.1k
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
02/13/2023 10-Q Quarterly Report for the period ended December 31, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy